Fri, November 13, 2020
Thu, November 12, 2020
Wed, November 11, 2020
Tue, November 10, 2020
Mon, November 9, 2020
Fri, November 6, 2020
Thu, November 5, 2020

Andrew Fein Maintained (BIIB) at Strong Buy with Decreased Target to $289 on, Nov 9th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-289-on-nov-9th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $318 to $289 on, Nov 9th, 2020.

Andrew has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 5 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Initiated at Hold and Held Target at $268 on, Wednesday, October 28th, 2020
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $282 on, Tuesday, October 27th, 2020
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $357 on, Thursday, October 22nd, 2020

Publication Contributing Sources